Results 201 to 210 of about 183,540 (315)

A two-step approach to simultaneously correct for selection and misclassification bias in nonprobability samples from hard-to-reach populations. [PDF]

Am J Epidemiol
Dharma C, Dharma C, Smith P, Salway T, Gesink D, Escobar M, Landsman V.   +6 more
europepmc   +1 more source

An unbiased channel estimator for space-time block coding under rayleigh fading

, 2010
Nuha A. S. Alwan, Zahir M. Hussain
openalex  

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

New robust estimator for handling outliers and multicollinearity in gamma regression model with application to breast cancer data. [PDF]

Sci Rep
Alshangiti AM, Gemeay AM, Bakr ME, Yousuf AM, El-Qurashi MA, Balogun OS, Hussam E, Hammad AT.   +7 more
europepmc   +1 more source

Empirical comparison of improved regression estimators of heritability in crossbred cattle

, 1995
Subhash Chander, U C Jaiswal
openalex   +1 more source

Estimation of photovoltaic potential on residential rooftops using empirical Bayesian estimator

, 2015
Joel Villavicencio Gastelu, Joel D. Melo, Antônio Padilha Feltrin   +2 more
openalex   +2 more sources

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Pseudo-Observation Approach for Length-Biased Cox Proportional Hazards Model. [PDF]

Biom J
Akbari M, Rad NN, Chen DG.
europepmc   +1 more source

Estimating eigenvalues [PDF]

Proceedings of the American Mathematical Society, 1952
openaire   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source